Navigation Links
ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results
Date:3/16/2010

SAN DIEGO, March 16 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the fourth quarter and year ended December 31, 2009.

"ADVENTRX begins 2010 with a strong balance sheet reflecting $22.7 million in cash, taking into account the net proceeds from the equity financing in January 2010, against 2009 operating expenses of $11.6 million," said Brian M. Culley, ADVENTRX's Chief Executive Officer.  "This capital will enable us to continue on-going stability studies from the intended commercial manufacturer of ANX-530, which we expect will be required to file the ANX-530 New Drug Application, and development of our detergent-free reformulation of the blockbuster chemotherapy drug, Taxotere."

"We look forward to meeting with the Food and Drug Administration to discuss filing requirements for our ANX-530 NDA, as well as the results of our ANX-514 bioequivalence study," Mr. Culley continued.  

Fourth Quarter 2009 Operating Results


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. ADVENTRX Receives Brand Name Acceptance for ANX-530
2. ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
3. ADVENTRX Announces Management Promotions
4. ADVENTRX Appoints Icahn Representative to Board of Directors
5. ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9
6. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
7. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
8. ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
9. ADVENTRX Pharmaceuticals Announces Closing of Financing
10. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
11. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... focused on the development and commercialization of a ... diseases and cholesterol gallstones, announced today that the ... approved its request for Fast Track Designation of ... Non-Alcoholic Steato-Hepatitis, or NASH.  FDA ...
(Date:9/23/2014)... 2014 FDNA® ( ... will exhibit at the 2014 ASHG meeting, booth #1035, ... will present the latest version of Face2Gene - the ... analysis technology. Face2Gene facilitates the detection of facial dysmorphic ... photos. The new version of Face2Gene includes ...
(Date:9/23/2014)... MCHENRY, Ill. , Sept. 23, 2014  Medela ... with Atlanta Biomedical Company (ABC), assigning Medela as the ... 4100), now known as the Medela Enteral Feeding Pump. ... position to help NICU parents and healthcare professionals by ... The Medela Enteral Feeding Pump is integral to ...
Breaking Medicine Technology:Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH 2Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH 3FDNA to Exhibit at ASHG2014 Presenting Face2Gene Integrated With London Medical Databases (LMD) Online 2Medela Enters Exclusive Enteral Feeding Pump Agreement with Atlanta Biomedical Company 2
... Laser,Centers, the largest provider of laser hair removal ... the addition of the VelaShape,cellulite reduction and body ... 30 additional locations before the end of March, ... FDA-approved for both cellulite,reduction and circumferential reduction of ...
... has,received its third $10 million tranche of equity funding ... milestones:,validating the efficacy and safety of its two topical ... influenza vaccine in,ferret studies., The company, a spin-off ... $30 million over the past 18 months from Perseus ...
Cached Medicine Technology:American Laser Center Offers VelaShape Body Shaping and Cellulite Reduction Treatment 2NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones 2
(Date:9/23/2014)... Trevera provides multiple lines of ... Oracle Managed Services , Oracle Solutions , ... of Oracle E-Business Databases and Applications, including ... has announced a significant enhancement to its service ... their software technology management, project management, governance, steering, ...
(Date:9/23/2014)... 2014 SOURCE: Solutions from Our ... were made to Rimidi Diabetes and ... with business solutions to challenges faced by patients and ... collaboration between The Hitachi Foundation, Village ... entrepreneurs with the investment capital, mentoring, and support needed ...
(Date:9/23/2014)... Dennis Thompson HealthDay Reporter ... Coupled with worldwide marches demanding action on climate change, ... weather patterns in the United States may soon exacerbate ... and other heat-related illnesses are expected to increase as ... author Dr. Jonathan Patz, director of the Global Health ...
(Date:9/23/2014)... Mich. They are common suggestions to remedy stress: You ... Get out and see people. , Turns out ... better a lot better a new large scale ... lower depression, less perceived stress and enhanced mental health and ... Michigan, with partners from De Montfort University, James Hutton Institute, ...
(Date:9/23/2014)... biology and a researcher in UTSA,s South Texas Center ... at Ruhr University in Bochum, Germany to understand how ... this week in an article published by the ... Cholera is an acute infection caused by ingestion of ... Vibrio cholerae . An estimated three to five ...
Breaking Medicine News(10 mins):Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 4Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 5Health News:Health Woes to Worsen Due to Climate Change, Study Warns 2Health News:Health Woes to Worsen Due to Climate Change, Study Warns 3Health News:Beating stress outdoors? Nature group walks may improve mental health 2Health News:UTSA microbiologists discover regulatory thermometer that controls cholera 2
... , , , ... this time from the trading floor. While there has long been ... new research by the Kellogg School of Management at Northwestern University, ... of Chicago,s Department of Comparative Human Development explores how the hormone ...
... pressure lead to decreases in cognition, study shows , MONDAY, ... to loss of mental function in people over 45, a ... looked at the relationship between blood pressure and cognitive function," ... the University of Alabama at Birmingham School of Public Health, ...
... , , , ... Hospital Corporation of America (HCA), dozens of registered nurses from HCA ... show their support of nurses from the company,s MountainView Hospital, after ... California Nurses Association/National Nurses Organizing Committee (CNA/NNOC). , , ...
... use, , MONDAY, Aug. 24 (HealthDay News) -- Kids should be ... "hanging out" at home, child health experts warn. , That,s because ... -- can compress the chest and lead to lower levels of ... Pediatrics . , "There are people who have no ...
... , ATLANTA, Aug. 24 Benchmark ... largest direct retailer of foot and lower body healthcare products ... Since 1989, the company has upheld two consumer commitments: smarter, ... providing expert customer information and service. FootSmart offers a full ...
... , , MENLO PARK, ... development of devices for the percutaneous repair of cardiac valves, ... the MitraClip(R) system at the Karolinska University Hospital in Solna, ... commercially available in the European Union which provides a non-surgical ...
Cached Medicine News:Health News:Risky Business: New Study Explores Role of Gender, Testosterone in Financial Risk Aversion 2Health News:Risky Business: New Study Explores Role of Gender, Testosterone in Financial Risk Aversion 3Health News:Risky Business: New Study Explores Role of Gender, Testosterone in Financial Risk Aversion 4Health News:Hypertension Linked to Thinking Problems in Middle Age 2Health News:Hypertension Linked to Thinking Problems in Middle Age 3Health News:Nurses from HCA Hospitals Nationwide Rally in Support of MountainView RNs Today 2Health News:Car Seats Can Limit Kids' Oxygen Supplies 2Health News:Car Seats Can Limit Kids' Oxygen Supplies 3Health News:Benchmark Brands Celebrates 20th Anniversary 2Health News:First Swedish Patients Receive MitraClip(R) Therapy 2Health News:First Swedish Patients Receive MitraClip(R) Therapy 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: